Community acquired pneumonia: practical Recommendations
##plugins.themes.bootstrap3.article.sidebar##
PDF (Español (España))
FLIP
HTML (Español (España))
##plugins.themes.bootstrap3.article.main##
Introduction. Acute respiratory infections (ARI) and particularly, community-acquired pneumonia are among the main causes of visiting the doctor’s and admissions to hospitals. ARI are also regarded as one of the main causes of inappropriate use of antibiotics. Materials and methods. A review of the main international consensus on diagnosis and treatment of community-acquired pneumonia is carried out. Conclusions. All international consensus have similar recommendations, both in the classification of patients and in the type of initial therapy.
Downloads
##plugins.themes.bootstrap3.article.details##
Brown S, Jones B E, Jephson A, Dean N. (2009). Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Critical Care Medicine, 37(12):3010-3016.
Valencia M, Badia J, Cavalcanti M, Ferrer M, Agustí C, Angrill J, García E, Mensa J, Niederman M, Torres A. (2007). Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia. Characteristics,Outcomes, and Value of Severity Scores CHEST, 132(2):515-522.
Buising KL, Thursky KA, Black JA, Mac Gregor L, Street AC, Kennedy MP, Brown, GV. (2006). A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax, 61:419-424.
Cereceda J, Maturana R. Acavedo V, Aylwin M, Flores M. (2003). Índice de gravedad en neumonía comunitaria hospitalizada. Rev Chil Enf Respir, 19:155-159.
Chalmers J, Singanayagam A, Hill A. (2008). Predicting the Need for Mechanical Ventilation and/or Inotropic Support for Young Adults Admitted to the Hospital with Community-Acquired Pneumonia. Clinical Infectious Diseases, 47(12):1571-1574.
España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, et al. (2006). Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med,174:1249-56.
Brown S, Dean N. (2010). Defining and Predicting Severe Community-Acquired Pneumonia (SCAP). Curr Opin Infect Dis,23(2):158-164.
Boletín de Información terapéutica para la APS en Cuba. Guía de práctica clínica para el tratamiento de la neumonía adquirida en la comunidad. Boletín No.25 Junio (2009). ISSN: 1608-7518.
Moreno R, Riquelme R. (2005). Etiología de la neumonía adquirida en la comunidad en el adulto inmunocompetente. Rev. Chil Enf Respir, 21:81-8.
Fernández R, Mauricio, Zagolin B, Mónica, Ruiz C, Mauricio et al. (2003). Neumonía adquirida en la comunidad que se hospitaliza: estudio etiológico. Rev. Méd. Chile, mayo 131(5):498-504.
Alós JI. Quinolonas. (2003). Rev Enfer Infecc Microb Clin, 21(5):261-268.
Wayne, PA. (2008). Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th informational supplement. CLSI document M100-S18.
Luna CM, Efrom ED, Schiavi y cols. (2003). Neumonía adquirida en la comunidad en adultos. Guía práctica clínica para la Argentina. Medicina, 63:319-343.
Díaz A, Labarca J, Pérez C, Ruiz M, Wolff M.(2005).Tratamiento de la neumonía del adulto adquirida en la comunidad. Rev Chil Enf Respir, 21:117-131.
Martínez P, Mattar S. (2007). Emergencia de la resistencia debido a betalactamasas de espectro extendido (BLEE) detección, impacto clínico y epidemiologia. Infectio, 11(1):23-25.
Lim WS. (2009). Pneumonia Guidelines Committee of the BTS Standards of Care Committee. The British Thoracic Society Guidelines for the management of Community Acquired Pneumonia in adults update. Disponible online en: www.brit-horacic.org.uk/clinical-information/pneumonia/pneumonia-guidelines.
Bantar C, Bavestrello L, Curcio D, Jasovich A. y Grupo ConsenSur. (2002). Neumonía adquirida en la comunidad en adultos. Guía para la terapia empírica inicial basada en evidencia local de un grupo de trabajo sudamericano (ConsenSur). Journal of Chemotherapy, 14(4):1-30.
Menéndez K, Aspa J, Capelastegui A, Prat C, Rodríguez F. (2010). Normativa de neumonía adquirida en la comunidad. Madrid: Editorial Respira, pp. 23-25.
Agudelo CI, Castañeda E, Corso A, Regueira M, Cunto MC, Pires A, Maldonado A et al. (2009). Resistencia a antibióticos no betalactámicos de aislamientos invasores de Streptococcus pneumoniae en niños latinoamericanos. SIREVA II, 2000-2005. Rev Panam Salud Publica/Pan Am J Public Health, 25(4).
Daum R. (2007). Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. N Engl J Med, 357:380-90.
Oosterheert J, Bonten M, Schneider M, Buskens E, Lammers J, Hustinx W et al. (2006). Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia. Multicentre randomized trial. BMJ, 333-1193.
Menéndez R, Martínez R, Reyes S, Mensa J, Filella X, Marcos A y col. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009;64:587-591
Mira JP, Max A, Burgel PR. The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Critical Care 2008; 12(Suppl 6):S5
